Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of MXN 2.71 trillion. The enterprise value is 3.64 trillion.

Market Cap	2.71T
Enterprise Value	3.64T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.58%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 19.34 and the forward PE ratio is 9.29.

PE Ratio	19.34
Forward PE	9.29
PS Ratio	2.40
PB Ratio	1.73
P/TBV Ratio	n/a
P/FCF Ratio	16.56
P/OCF Ratio	12.84
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.94, with an EV/FCF ratio of 22.28.

EV / Earnings	26.02
EV / Sales	3.38
EV / EBITDA	7.94
EV / EBIT	11.04
EV / FCF	22.28

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.68%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.68%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	5.57%
Revenue Per Employee	13.91M
Profits Per Employee	1.73M
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-4.79B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.46% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-11.46%
50-Day Moving Average	457.60
200-Day Moving Average	459.77
Relative Strength Index (RSI)	57.86
Average Volume (20 Days)	11,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.05

Income Statement

In the last 12 months, Pfizer had revenue of MXN 1.13 trillion and earned 139.90 billion in profits. Earnings per share was 24.56.

Revenue	1.13T
Gross Profit	854.05B
Operating Income	345.01B
Pretax Income	135.40B
Net Income	139.90B
EBITDA	463.01B
EBIT	345.01B
Earnings Per Share (EPS)	24.56

Full Income Statement

Balance Sheet

The company has 244.77 billion in cash and 1.22 trillion in debt, giving a net cash position of -973.09 billion.

Cash & Cash Equivalents	244.77B
Total Debt	1.22T
Net Cash	-973.09B
Net Cash Per Share	n/a
Equity (Book Value)	1.56T
Book Value Per Share	273.80
Working Capital	106.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 210.71 billion and capital expenditures -47.33 billion, giving a free cash flow of 163.38 billion.

Operating Cash Flow	210.71B
Capital Expenditures	-47.33B
Free Cash Flow	163.38B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 31.92, which amounts to a dividend yield of 6.72%.

Dividend Per Share	31.92
Dividend Yield	6.72%
Dividend Growth (YoY)	-0.15%
Years of Dividend Growth	2
Payout Ratio	125.74%
Buyback Yield	-0.23%
Shareholder Yield	6.49%
Earnings Yield	5.17%
FCF Yield	6.04%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6